Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Change in Account Payables for 6 consecutive years, with $549000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 167.8% to $549000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 184.7% year-over-year, with the annual reading at $1.6 million for FY2025, 184.7% up from the prior year.
  • Change in Account Payables hit $549000.0 in Q4 2025 for Rapid Micro Biosystems, up from $251000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.9 million in Q3 2023 to a low of -$4.1 million in Q1 2023.
  • Historically, Change in Account Payables has averaged -$16650.0 across 5 years, with a median of $125000.0 in 2024.
  • Biggest five-year swings in Change in Account Payables: crashed 1037.5% in 2022 and later soared 1219.48% in 2024.
  • Year by year, Change in Account Payables stood at $1.7 million in 2021, then increased by 3.96% to $1.8 million in 2022, then crashed by 173.79% to -$1.3 million in 2023, then surged by 115.79% to $205000.0 in 2024, then soared by 167.8% to $549000.0 in 2025.
  • Business Quant data shows Change in Account Payables for RPID at $549000.0 in Q4 2025, $251000.0 in Q3 2025, and $700000.0 in Q2 2025.